{
    "ticker": "INMU",
    "name": "InMode Ltd.",
    "description": "InMode Ltd. is a global leader in the development of innovative aesthetic medical technologies that enhance patient outcomes and physician experiences. Founded in 2008, InMode specializes in minimally invasive and non-invasive procedures, focusing on the fields of rejuvenation, body contouring, and surgical solutions. The company\u2019s proprietary technologies, including radio-frequency and laser-based systems, are designed to provide safe and effective treatment options for a variety of aesthetic conditions. InMode's flagship products, such as the BodyTite, FaceTite, and Morpheus8, have gained wide recognition for their ability to deliver impressive results with minimal downtime, thereby transforming the landscape of aesthetic medicine. As a publicly traded company on the NASDAQ, InMode is committed to research and development, continually advancing its product portfolio to meet the evolving needs of medical professionals and their patients. The company's mission is to empower practitioners with effective and innovative solutions, ultimately enhancing the quality of life for individuals seeking aesthetic improvements.",
    "industry": [
        "Medical Devices",
        "Aesthetic Medicine"
    ],
    "headquarters": "Ra'anana, Israel",
    "founded": "2008",
    "website": "https://www.inmodemd.com",
    "ceo": "Moshe Mizrahy",
    "social_media": {
        "twitter": "https://twitter.com/InModeMed",
        "linkedin": "https://www.linkedin.com/company/inmode/"
    },
    "investor_relations": "https://investors.inmodemd.com",
    "key_executives": [
        {
            "name": "Moshe Mizrahy",
            "position": "CEO"
        },
        {
            "name": "Reuven A. Koren",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Aesthetic Devices",
            "products": [
                "BodyTite",
                "FaceTite",
                "Morpheus8",
                "EmbraceRF"
            ]
        },
        {
            "category": "Surgical Solutions",
            "products": [
                "Liposuction Devices",
                "Renuvion"
            ]
        }
    ],
    "seo": {
        "meta_title": "InMode Ltd. | Innovative Aesthetic Medical Technologies",
        "meta_description": "InMode Ltd. is a leader in aesthetic medical technologies, offering innovative solutions for rejuvenation and body contouring. Explore InMode's cutting-edge products and commitment to enhancing patient care.",
        "keywords": [
            "InMode",
            "Aesthetic Medicine",
            "Body Contouring",
            "Rejuvenation",
            "Minimally Invasive Procedures",
            "Medical Devices"
        ]
    },
    "faq": [
        {
            "question": "What is InMode known for?",
            "answer": "InMode is known for its innovative aesthetic medical technologies, including minimally invasive and non-invasive devices."
        },
        {
            "question": "Who is the CEO of InMode?",
            "answer": "Moshe Mizrahy is the CEO of InMode Ltd."
        },
        {
            "question": "Where is InMode headquartered?",
            "answer": "InMode is headquartered in Ra'anana, Israel."
        },
        {
            "question": "What are InMode's main products?",
            "answer": "InMode's main products include BodyTite, FaceTite, Morpheus8, and Renuvion."
        },
        {
            "question": "When was InMode founded?",
            "answer": "InMode was founded in 2008."
        }
    ],
    "competitors": [
        "ALGN",
        "HCA",
        "SRTS",
        "CYN"
    ],
    "related_stocks": [
        "AAPL",
        "MSFT",
        "AMZN",
        "GOOGL"
    ]
}